Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Preclinical & Early Phase Research Early-phase research is a strategy-driven first step in the development of new drugs and medical devices. In drug development, pre-clinical studies are designed to provide detailed information on dosing and toxicity levels. This phase of development allows for the selection of the best novel agents to enter the clinical trial phase and to minimize failure in development. Pre-clinical evaluation is highly important for the development of innovative medical devices, as safety and efficacy testing enable the design of studies that fulfill regulatory requirements. DIA provides a forum, network, and resources for facilitating collaboration and insights exchange for professionals involved in pre-clinical and early-phase research.

Pharmacometrics: The Already-Present Future of Precision Pharmacology

Pharmacometrics Precision Pharmacology

The use of mathematical modeling to represent, analyze, make predictions or providing information on data obtained in drug research and development has made pharmacometrics an area of great prominence and importance. In this review, we describe the meaning, history, and development of pharmacometrics, analyzing the challenges faced in the training of professionals.

Read More

Submit an Abstract

DIA Abstract

Submit an abstract for an existing or future event on any topic that advances the pharmaceutical, biotechnology, medical device, and related fields.

Learn More

Learn More

Discovery and Pre-Clinical Phases Online Course

In this module, learners focus on how companies advance potential drug candidates through the earliest stages of research, from therapeutic target to readiness for clinical studies.

Learn More

Drug Development and Lifecycle Management eLearning Program

Understand how companies structure their efforts and utilize their resources to improve the odds of successful development, and potentially minimize the risks associated with shepherding a new drug candidate through the development process.

Learn More
Featured Networking and Knowledge Exchange

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.